Prednison

( DrugBank: - / KEGG DRUG: - )

3 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	61
84	Sarcoidosis	9

ID	Disease name (Link within this page)	Number of trials
113	Muscular dystrophy	17

46. Malignant rheumatoid arthritis

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

trials per page:

Showing 1 to 10 of 61 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05651373 (ClinicalTrials.gov)	July 30, 2021	15/11/2022	The Clinical Features and Pregnancy Outcomes of RA Patients	The Clinical Features and Pregnancy Outcomes of Patients With Rheumatoid Arthritis :a Prospective Co ...	Rheumatoid Arthritis;Pregnancy Related	Drug: Prednisone;Drug: Hydroxychloroquine;Drug: CertolizumabPegol injection	Qilu Hospital of Shandong University	NULL	Recruiting	20 Years	45 Years	Female	100		China
2	ChiCTR2100048802	2021-07-15	2021-07-16	A prospective non-randomized controlled study on the treatment of interstitial pneumonia of RA with ...	A prospective cohort study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedut ...	Rheumatoid arthritis with interstitial pneumonia	experimental group:Syndrome Differentiation and Flavoring of Peitushengjin Chinese Medicine Granules ...	Zhejiang Chinese Medical University	NULL	Pending	18	65	Both	experimental group:285;control group:240;	N/A	China
3	ITMCTR2100005066	2021-07-15	2021-07-16	A prospective non-randomized controlled study on the treatment of interstitial pneumonia of RA with ...	A prospective cohort study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedut ...	Rheumatoid arthritis with interstitial pneumonia	control group:Hydroxychloroquine + prednisone;experimental group:Syndrome Differentiation and Flavor ...	Zhejiang Chinese Medical University	NULL	Pending	18	65	Both	control group:240;experimental group:285;	N/A	China
4	ChiCTR2100041777	2021-01-01	2021-01-05	Clinical study on Juanbi granule in adjuvant hormone withdrawal of rheumatoid arthritis	Clinical study on Juanbi granule in adjuvant hormone withdrawal of rheumatoid arthritis	rheumatoid arthritis	Treatment group:Juanbi granule, Prednisone Acetate Tablets, Methotrexate and Leflunomide ;control gr ...	Yunnan Hospital of Traditional Chinese Medicine /The First Affiliated Hospital of Yunnan University ...	NULL	Recruiting	18	65	Both	Treatment group:62;control group:31;		China
5	ChiCTR2100041909	2021-01-01	2021-01-09	Clinical study on Yupingfengguizhi solution assisted hormone Withdrawal and reduction in rheumatoid ...	Clinical study on Yupingfengguizhi solution assisted hormone Withdrawal and reduction in rheumatoid ...	Rheumatoid arthritis	Treatment group:Yupingfengguizhi solution, Prednisone Acetate Tablets, Methotrexate, Leflunomide ;co ...	Yunnan Traditional Chinese Medicine Hospital	NULL	Recruiting	18	65	Both	Treatment group:62;control group:31;		China
6	ITMCTR2100004239	2021-01-01	2021-01-09	Clinical study on Yupingfengguizhi solution assisted hormone Withdrawal and reduction in rheumatoid ...	Clinical study on Yupingfengguizhi solution assisted hormone Withdrawal and reduction in rheumatoid ...	Rheumatoid arthritis	control group:Prednisone Acetate Tablets, Methotrexate, Leflunomide;Treatment group:Yupingfengguizhi ...	Yunnan Traditional Chinese Medicine Hospital	NULL	Recruiting	18	65	Both	control group:31;Treatment group:62;		China
7	ITMCTR2100004610	2021-01-01	2021-01-05	Clinical study on Juanbi granule in adjuvant hormone withdrawal of rheumatoid arthritis	Clinical study on Juanbi granule in adjuvant hormone withdrawal of rheumatoid arthritis	rheumatoid arthritis	control group:Prednisone Acetate Tablets, Methotrexate and Leflunomide;Treatment group:Juanbi granul ...	Yunnan Hospital of Traditional Chinese Medicine /The First Affiliated Hospital of Yunnan University ...	NULL	Recruiting	18	65	Both	control group:31;Treatment group:62;		China
8	NCT04569890 (ClinicalTrials.gov)	December 1, 2020	20/9/2020	Treatment of Pregnancy RA	Study on the Treatment Strategy of Patients With Rheumatoid Arthritis During Pregnancy, a Randomized ...	Rheumatoid Arthritis;Pregnancy Related	Drug: Certolizumab Pegol 200 MG/ML [Cimzia];Drug: Hydroxychloroquine;Drug: Prednisone	RenJi Hospital	NULL	Not yet recruiting	20 Years	40 Years	Female	100	N/A	China
9	EUCTR2018-004287-56-FR (EUCTR)	21/11/2019	31/01/2020	Methotrexate and Metformin in rheumatoid arthritis patients	Randomized placebo-controlled trial comparing Methotrexate vs. Methotrexate/Metformin association in ...	rheumatoid arthritis (RA) MedDRA version: 20.0;Level: HLT;Classification code 10039075;Term: Rheumat ...	Trade Name: METFORMINE ARROW 500mg Product Name: Metformin Trade Name: Methotrexate Product Name: Metho ...	CHU de Bordeaux	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	128	Phase 2	France
10	EUCTR2017-003037-28-NL (EUCTR)	02/10/2019	22/07/2019	Efficacy of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficie ...	Efficacy of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficie ...	RA patients with active RA despite treatment with DMARDs. MedDRA version: 23.1;Level: PT;Classificat ...	Trade Name: RoActemra INN or Proposed INN: TOCILIZUMAB Other descriptive name: TOCILIZUMAB Trade Name: ...	University Medical Center Utrecht	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 4	Netherlands

First Previous1 2 3 4 5 6 7Next Last

84. Sarcoidosis

Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169

trials per page:

Showing 1 to 9 of 9 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05247554 (ClinicalTrials.gov)	March 1, 2022	9/2/2022	Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary ...	Randomized Controlled Trial Testing the Effect of Hydroxychloroquine Combined With Low-dose Corticos ...	Pulmonary Sarcoidosis	Drug: Hydroxychloroquine + low-dose prednisone;Drug: Prednisone	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	18 Years	80 Years	All	200	Phase 3	NULL
2	JPRN-jRCTs011210048	05/11/2021	05/11/2021	Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial	Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial - CHASM CS- RCT	Cardiac Sarcoidosis Cardiac Sarcoidosis	Subjects meeting the study inclusion/exclusion criteria will be randomized equally to receive either ...	Toshiyuki Nagai	NULL	Pending	>= 18age old	Not applicable	Both	194	Phase 3	Canada;United States;United Kingdom;Japan
3	EUCTR2019-004148-31-NL (EUCTR)	26/02/2020	15/11/2019	The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmon ...	The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmon ...	pulmonary sarcoidosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]	Trade Name: Methotrexate Product Name: methotrexate INN or Proposed INN: methotrexate Other descriptive ...	Erasmus Medisch Centrum Dept. of Pulmonology	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	132	Phase 4	Netherlands
4	NCT03593759 (ClinicalTrials.gov)	January 15, 2019	27/6/2018	Cardiac Sarcoidosis Randomized Trial	Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial	Cardiac Sarcoidosis;Sarcoidosis	Drug: Prednisone or Prednisolone;Drug: Methotrexate	Ottawa Heart Institute Research Corporation	Canadian Institutes of Health Research (CIHR)	Recruiting	18 Years	N/A	All	194	Phase 3	United States;Canada;Japan;United Kingdom
5	NCT03324503 (ClinicalTrials.gov)	December 8, 2017	12/10/2017	A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Thera ...	A Multicenter, Open-Label Study to Estimate the Effect Sizes of HRCT Endpoints in Response to GLUCOC ...	Sarcoidosis, Pulmonary	Drug: Glucocorticoid (prednisone or prednisolone)	Celgene	NULL	Completed	18 Years	65 Years	All	8	N/A	United States;Netherlands;United Kingdom
6	NCT01210677 (ClinicalTrials.gov)	April 2014	27/9/2010	Cardiac Sarcoidosis Response To Steroids Trial	CArdiac Sarcoidosis Response TO steRoids (CASTOR) Trial	Cardiac Sarcoidosis;Sarcoidosis	Drug: Prednisone	Ottawa Heart Institute Research Corporation	NULL	Withdrawn	18 Years	N/A	Both	0	Phase 4	Canada
7	NCT02200146 (ClinicalTrials.gov)	March 2009	10/7/2014	Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).	Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). A Multicenter, Prospe ...	Pulmonary Sarcoidosis	Drug: Prednisone;Drug: Hydroxychloroquine + Prednisone	University of Milano Bicocca	Agenzia Italiana del Farmaco	Completed	18 Years	70 Years	Both	94	Phase 3	Italy
8	EUCTR2008-001340-39-IT (EUCTR)	30/06/2008	13/06/2008	Hydroxychloroquine as Steroid-Sparing Agent in pulmonary Sarcoidosis (HySSAS). A multicenter, prospe ...	Hydroxychloroquine as Steroid-Sparing Agent in pulmonary Sarcoidosis (HySSAS). A multicenter, prospe ...	Pulmonary Sarcoidosis	Trade Name: PLAQUENIL*25CPR RIV 200MG INN or Proposed INN: Hydroxychloroquine Trade Name: DELTACORTENE ...	UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy
9	NCT00000596 (ClinicalTrials.gov)	June 1978	27/10/1999	Diffuse Fibrotic Lung Disease		Lung Diseases;Pulmonary Fibrosis;Sarcoidosis	Drug: prednisone;Drug: cyclophosphamide;Drug: dapsone	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	18 Years	N/A	Both		Phase 2	NULL

First Previous1Next Last

113. Muscular dystrophy

Clinical trials : 646 / Drugs : 471 - (DrugBank : 105) / Drug target genes : 59 - Drug target pathways : 170

trials per page:

Showing 1 to 10 of 17 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04322357 (ClinicalTrials.gov)	July 30, 2020	24/3/2020	Weekend Steroids and Exercise as Therapy for DMD	Impact and Interplay of Corticosteroid Regimen and Exercise Training on DMD Muscle Function	Duchenne Muscular Dystrophy (DMD)	Drug: Prednisone;Behavioral: In-home Exercise Training;Drug: Prednisone with daily edasalonexent;Dru ...	University of Florida	U.S. Army Medical Research and Development Command;Catabasis Pharmaceuticals	Recruiting	5 Years	8 Years	Male	89	Phase 2	United States
2	EUCTR2017-002704-27-NL (EUCTR)	10/10/2019	25/02/2019	A Study to Assess the efficacy and the safety of Vamorolone in Boys with Duchenne Muscular Dystrophy ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Doub ...	Duchenne muscular dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Vamorolone Product Code: VBP15 INN or Proposed INN: VAMOROLONE Product Name: Vamorolone Pr ...	ReveraGen BioPharma, Inc.	NULL	Not Recruiting			Female: no Male: yes	120	Phase 2	United States;Czechia;Greece;Spain;Israel;Italy;United Kingdom;Czech Republic;Canada;Belgium;Austral ...
3	EUCTR2017-002704-27-ES (EUCTR)	13/08/2019	11/06/2019	A Study to Assess the efficacy and the safety of Vamorolone in Boys with Duchenne Muscular Dystrophy ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Doub ...	Duchenne muscular dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Vamorolone Product Code: VBP15 INN or Proposed INN: VAMOROLONE Product Name: Vamorolone Pr ...	ReveraGen BioPharma, Inc.	NULL	Not Recruiting			Female: no Male: yes	120	Phase 2	United States;Greece;Spain;Israel;Italy;United Kingdom;Czech Republic;Canada;Belgium;Australia;Germa ...
4	EUCTR2017-002704-27-GR (EUCTR)	01/08/2019	10/06/2019	A Study to Assess the efficacy and the safety of Vamorolone in Boys withDuchenne Muscular Dystrophy ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- andActive-controlled Study with Doubl ...	Duchenne muscular dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Vamorolone Product Code: VBP15 INN or Proposed INN: VAMOROLONE Product Name: Vamorolone Pr ...	ReveraGen BioPharma, Inc	NULL	Not Recruiting			Female: no Male: yes	120	Phase 2	Czech Republic;Canada;Greece;Spain;Belgium;Australia;Israel;Netherlands;Germany;United Kingdom;Italy ...
5	EUCTR2017-002704-27-BE (EUCTR)	06/07/2019	21/02/2018	A Study to Assess the efficacy and the safety of Vamorolone in Boys with Duchenne Muscular Dystrophy ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Doub ...	Duchenne muscular dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Vamorolone Product Code: VBP15 INN or Proposed INN: VAMOROLONE Product Name: Vamorolone Pr ...	ReveraGen BioPharma, Inc.	NULL	Not Recruiting			Female: no Male: yes	120	Phase 2	United States;Czechia;Greece;Spain;Israel;Italy;United Kingdom;Czech Republic;Canada;Belgium;Austral ...
6	NCT04054375 (ClinicalTrials.gov)	July 1, 2019	7/8/2019	Weekly Steroids in Muscular Dystrophy	Open Label Safety and Efficacy of Once Weekly Steroid in Patients With LGMD and Becker Muscular Dyst ...	Limb-girdle Muscular Dystrophy;Becker Muscular Dystrophy	Drug: Prednisone	Northwestern University	NULL	Active, not recruiting	18 Years	65 Years	All	20	Phase 2	United States
7	EUCTR2017-002704-27-CZ (EUCTR)	19/06/2019	22/03/2019	A Study to Assess the efficacy and the safety of Vamorolone in Boys with Duchenne Muscular Dystrophy ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Doub ...	Duchenne muscular dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Vamorolone Product Code: VBP15 INN or Proposed INN: VAMOROLONE Product Name: Prednisone IN ...	ReveraGen BioPharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	120	Phase 2	United States;Greece;Spain;Israel;United Kingdom;Italy;Czech Republic;Canada;Belgium;Australia;Germa ...
8	EUCTR2017-002704-27-GB (EUCTR)	21/09/2018	25/06/2019	A Study to Assess the efficacy and the safety of Vamorolone in comparison to Prednisone in Boys with ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Doub ...	Duchenne muscular dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Vamorolone Product Code: VBP15 INN or Proposed INN: VAMOROLONE Product Name: Vamorolone Pr ...	ReveraGen BioPharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	120	Phase 2	United States;Greece;Spain;Israel;United Kingdom;Italy;Czech Republic;Canada;Belgium;Australia;Germa ...
9	EUCTR2017-002704-27-SE (EUCTR)	15/08/2018	12/03/2018	A Study to Assess the efficacy and the safety of Vamorolone in Boys with Duchenne Muscular Dystrophy ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Doub ...	Duchenne muscular dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Vamorolone Product Code: VBP15 INN or Proposed INN: VAMOROLONE Product Name: Vamorolone Pr ...	ReveraGen BioPharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	120	Phase 2	United States;Czechia;Greece;Spain;Israel;Italy;United Kingdom;Czech Republic;Canada;Belgium;Austral ...
10	NCT03439670 (ClinicalTrials.gov)	June 29, 2018	9/1/2018	A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DM ...	A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study With Doub ...	Duchenne Muscular Dystrophy	Drug: Vamorolone;Drug: Prednisone;Other: Placebo	ReveraGen BioPharma, Inc.	European Union;Cooperative International Neuromuscular Research Group;Newcastle University;Universit ...	Completed	4 Years	7 Years	Male	121	Phase 2	United States;Australia;Belgium;Canada;Czechia;Greece;Israel;Netherlands;Spain;Sweden;United Kingdom ...

First Previous1 2Next Last